Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer
NCT07271823
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer Non-resectable
Interventions
OTHER:
Sample Collection
Sponsor
Zhejiang Cancer Hospital